Characterization of the metabolic phenotype of chronically activated lymphocytes

Lupus

Volumn 19, Issue 13, 2010, Pages 1492-1501

  Wahl, D R ^a   Petersen, B ^b   Warner, R ^b   Richardson, B C ^b   Glick, G D ^a   Opipari, A W ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

chronic stimulation; glycolysis; lupus; lymphocytes; metabolism; oxidative phosphorylation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARBON 13; GLUCOSE; LACTIC ACID;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE OXIDATION; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; STIMULATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS; CELLS, CULTURED; FEMALE; GLUCOSE; GLYCOLYSIS; HUMANS; LACTIC ACID; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED NZB; OXIDATION-REDUCTION; PHENOTYPE; SPLEEN; T-LYMPHOCYTES;

EID: 78649269147     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310373109     Document Type: Article

References (71)

1. Fox CJ, Hammerman PS, Thompson CB Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol 2005 ; 5: 844-852.
2. Acuto O., Michel F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol 2003 ; 3: 939-951.
3. Og'Rourke AM, Rider CC Glucose, glutamine and ketone body utilisation by resting and concanavalin A activated rat splenic lymphocytes. Biochim Biophys Acta 1989 ; 1010: 342-345.
4. Guppy M., Greiner E., Brand K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur J Biochem 1993 ; 212: 95-99.
5. Roos D., Loos JA Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. II. Relative importance of glycolysis and oxidative phosphorylation on phytohaemagglutinin stimulation. Exp Cell Res 1973 ; 77: 127-135.
6. Jones RG, Bui T., White C., et al. The proapoptotic factors Bax and Bak regulate T cell proliferation through control of endoplasmic reticulum Ca(2+) homeostasis. Immunity 2007 ; 27: 268-280.
7. Baumgarten E., Brand MD, Pozzan T. Mechanism of activation of pyruvate dehydrogenase by mitogens in pig lymphocytes. Biochem J 1983 ; 216: 359-367.
8. Frauwirth KA, Riley JL, Harris MH, et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 2002 ; 16: 769-777.
9. Vaughn AE, Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat Cell Biol 2008 ; 10: 1477-1483.
10. Brand KA, Hermfisse U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J 1997 ; 11: 388-395.
11. Vander Heiden MG, Cantley LC, Thompson CB Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009 ; 324: 1029-1033.
12. Rahman A., Isenberg DA Systemic lupus erythematosus. N Engl J Med 2008 ; 358: 929-939.
13. Beeton C., Wulff H., Barbaria J., et al. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci U S A 2001 ; 98: 13942-13947.
14. Decker P., Kotter I., Klein R., Berner B., Rammensee HG Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2006 ; 45: 1087-1095.
15. Folzenlogen D., Hofer MF, Leung DY, Freed JH, Newell MK Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol 1997 ; 83: 199-204.
16. Koshy M., Berger D., Crow MK Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 1996 ; 98: 826-837. (Pubitemid 26349188)
17. Shlomchik MJ, Craft JE, Mamula MJ From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 2001 ; 1: 147-153.
18. Vallejo AN CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005 ; 205: 158-169.
19. Wulff H., Calabresi PA, Allie R., et al. The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest 2003 ; 111: 1703-1713.
20. Benke PJ, Drisko J., Ahmad P. Increased oxidative metabolism in phytohemagglutinin-stimulated lymphocytes from patients with systemic lupus erythematosus is associated with serum SSA antibody. Biochem Med Metab Biol 1991 ; 45: 28-40.
21. Kuhnke A., Burmester GR, Krauss S., Buttgereit F. Bioenergetics of immune cells to assess rheumatic disease activity and efficacy of glucocorticoid treatment. Ann Rheum Dis 2003 ; 62: 133-139.
22. Hitchon CA, El-Gabalawy HS Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004 ; 6: 265-278.
23. Zhou Q., Mrowietz U., Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med 2009 ; 47: 891-905.
24. Katz J., Lee WN, Wals PA, Bergner EA Studies of glycogen synthesis and the Krebs cycle by mass isotopomer analysis with [U-13C]glucose in rats. J Biol Chem 1989 ; 264: 12994-13004.
25. Maciver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL, Rathmell JC Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 2008 ; 84: 949-957.
26. Jongstra-Bilen J., Vukusic B., Boras K., Wither JE Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli. J Immunol 1997 ; 159: 5810-5820.
27. Ye YL, Suen JL, Chen YY, Chiang BL Phenotypic and functional analysis of activated B cells of autoimmune NZB x NZW F1 mice. Scand J Immunol 1998 ; 47: 122-126.
28. Honda M., Mengesha E., Albano S., et al. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus. Clin Immunol 2001 ; 99: 211-221.
29. Pawelec G., Rehbein A., Haehnel K., Merl A., Adibzadeh M. Human T-cell clones in long-term culture as a model of immunosenescence. Immunol Rev 1997 ; 160: 31-42.
30. Boumezbeur F., Besret L., Valette J., et al. Glycolysis versus TCA cycle in the primate brain as measured by combining 18F-FDG PET and 13C-NMR. J Cereb Blood Flow Metab 2005 ; 25: 1418-1423.
31. Gautier JF, Pirnay F., Lacroix M., et al. Changes in breath 13CO2/ 12CO2 during exercise of different intensities. J Appl Physiol 1996 ; 81: 1096-1102.
32. Kaibara T., Sutherland GR, Colbourne F., Tyson RL Hypothermia: depression of tricarboxylic acid cycle flux and evidence for pentose phosphate shunt upregulation. J Neurosurg 1999 ; 90: 339-347.
33. Boren J., Cascante M., Marin S., et al. Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J Biol Chem 2001 ; 276: 37747-37753.
34. Chen Y., Gorelik GJ, Strickland FM, Richardson BC Decreased ERK and JNK signaling contribute to gene overexpression in ''senescentg'g' CD4+CD28- T cells through epigenetic mechanisms. J Leukoc Biol 2009.
35. Sariban-Sohraby S., Magrath IT, Balaban RS Comparison of energy metabolism in human normal and neoplastic (Burkittg's lymphoma) lymphoid cells. Cancer Res 1983 ; 43: 4662-4664.
36. Lee WN, Bergner EA, Guo ZK Mass isotopomer pattern and precursor-product relationship. Biol Mass Spectrom 1992 ; 21: 114-122.
37. Ruzzin J., Peronnet F., Tremblay J., Massicotte D., Lavoie C. Breath [13CO2] recovery from an oral glucose load during exercise: comparison between [U-13C] and [1,2-13C]glucose. J Appl Physiol 2003 ; 95: 477-482.
38. Beger RD, Hansen DK, Schnackenberg LK, et al. Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-C(6)]-d-glucose tracer in mice. Metabolomics 2009 ; 5: 336-345.
39. Maechler P., Kennedy ED, Pozzan T., Wollheim CB Mitochondrial activation directly triggers the exocytosis of insulin in permeabilized pancreatic beta-cells. EMBO J 1997 ; 16: 3833-3841.
40. Lee WN, Boros LG, Puigjaner J., Bassilian S., Lim S., Cascante M. Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose. Am J Physiol 1998 ; 274: E843-851.
41. Boros LG, Steinkamp MP, Fleming JC, Lee WN, Cascante M., Neufeld EJ Defective RNA ribose synthesis in fibroblasts from patients with thiamine-responsive megaloblastic anemia (TRMA). Blood 2003 ; 102: 3556-3561.
42. Lee WN, Guo P., Lim S., et al. Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment. Br J Cancer 2004 ; 91: 2094-2100.
43. Bauer DE, Hatzivassiliou G., Zhao F., Andreadis C., Thompson CB ATP citrate lyase is an important component of cell growth and transformation. Oncogene 2005 ; 24: 6314-6322. (Pubitemid 43080054)
44. Buttgereit F., Brand MD, Muller M. ConA induced changes in energy metabolism of rat thymocytes. Biosci Rep 1992 ; 12: 381-386.
45. Homann D., Teyton L., Oldstone MB Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med 2001 ; 7: 913-919.
46. Foulds KE, Zenewicz LA, Shedlock DJ, Jiang J., Troy AE, Shen H. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J Immunol 2002 ; 168: 1528-1532.
47. Seder RA, Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 2003 ; 4: 835-842.
48. Schieke SM, Phillips D., McCoy Jr JP, et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 2006 ; 281: 27643-27652.
49. Buttgereit F., Burmester GR, Brand MD Therapeutically targeting lymphocyte energy metabolism by high-dose glucocorticoids. Biochem Pharmacol 2000 ; 59: 597-603.
50. Doughty CA, Bleiman BF, Wagner DJ, et al. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 2006 ; 107: 4458-4465.
51. Parry RV, Chemnitz JM, Frauwirth KA, et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 2005 ; 25: 9543-9553.
52. Moroni G., Novembrino C., Quaglini S., et al. Oxidative stress and homocysteine metabolism in patients with lupus nephritis. Lupus 2009.
53. Boveris A., Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 1973 ; 134: 707-716.
54. Perl A., Gergely Jr.P., Banki K. Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus. Int Rev Immunol 2004 ; 23: 293-313.
55. Bobe P., Bonardelle D., Benihoud K., Opolon P., Chelbi-Alix MK Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice. Blood 2006 ; 108: 3967-3975.
56. Nagy G., Barcza M., Gonchoroff N., Phillips PE, Perl A. Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells. J Immunol 2004 ; 173: 3676-3683.
57. Perl A., Gergely Jr.P., Nagy G., Koncz A., Banki K. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol 2004 ; 25: 360-367.
58. Weng NP, Akbar AN, Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 2009 ; 30: 306-312.
59. Hirashima M., Fukazawa T., Abe K., Morita Y., Kusaoi M., Hashimoto H. Expression and activity analyses of CTLA4 in peripheral blood lymphocytes in systemic lupus erythematosus patients. Lupus 2004 ; 13: 24-31.
60. Sharpe AH, Wherry EJ, Ahmed R., Freeman GJ The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007 ; 8: 239-245.
61. Fukuda R., Hirota K., Fan F., Jung YD, Ellis LM, Semenza GL Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002 ; 277: 38205-38211.
62. Laughner E., Taghavi P., Chiles K., Mahon PC, Semenza GL HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001 ; 21: 3995-4004.
63. Semenza GL, Jiang BH, Leung SW, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996 ; 271: 32529-32537.
64. Kim JW, Tchernyshyov I., Semenza GL, Dang CV HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006 ; 3: 177-185.
65. Lum JJ, Bui T., Gruber M., et al. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev 2007 ; 21: 1037-1049.
66. Wu T., Qin X., Kurepa Z., et al. Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest 2007 ; 117: 2186-2196.
67. Tuscano JM, Hsu TC, McKnight H., Ansari AA, Gershwin ME Phosphorylation abnormalities: NZB mice exhibit a B-cell signalling defect. J Autoimmun 2002 ; 19: 103-109.
68. Barber DF, Bartolome A., Hernandez C., et al. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med 2005 ; 11: 933-935.
69. Kojima H., Gu H., Nomura S., et al. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha- deficient chimeric mice. Proc Natl Acad Sci U S A 2002 ; 99: 2170-2174.
70. Blatt NB, Bednarski JJ, Warner RE, et al. Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility. J Clin Invest 2002 ; 110: 1123-1132.
71. Bednarski JJ, Warner RE, Rao T., et al. Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepine. Arthritis Rheum 2003 ; 48: 757-766.